Email updates

Keep up to date with the latest news and content from Genome Biology and BioMed Central.

Research news

Heart failure mutation

Jonathan B Weitzman

Citation and License

Genome Biology 2003, 4:spotlight-20030305-01  doi:10.1186/gb-spotlight-20030305-01

The electronic version of this article is the complete one and can be found online at:


Published:5 March 2003

© 2003 BioMed Central Ltd

Research news

Heart failure is a major cause of death in the developed world and a growing health-care concern. In the February 28 Science Schmitt et al. report the discovery of a mutation in patients suffering from inherited dilated cardiomyopathy with refractory congestive heart disease (Science 2003, 299:1410-1413). A dominant missense mutation (Arg→Cys) was found at residue 9 in phospholamban (PLN). Phospholamban is a 52 amino-acid transmembrane phosphoprotein that regulates the Ca2+ ATPase pump (SERCA2a). Schmitt et al. generated transgenic mice expressing the mutant PLNR9C in the heart and observed biventral cardiac dilation and progressive cardiomyopathy resembling the human symptoms. Tissue culture experiments demonstrated that the PLNR9C mutant form trapped protein kinase A (PKA), which led to inhibition of the phosphorylation of wild-type PLNWT protein and delayed decay of Ca2+ transients. Manipulating Ca2+ handling and/or PLN activity may provide a therapeutic opportunity for treating human heart disease.

References

  1. Recent advances in understanding the genetic etiology of congenital heart disease.

    PubMed Abstract OpenURL

  2. [http://www.sciencemag.org] webcite

    Science

  3. Phospholamban and cardiac contractility.

    PubMed Abstract OpenURL